There is reduced expression of desmoglein-2 (DSG2) in the endothelial cells of SSc patients shown by differential transcriptome profiling and by immunohistochemistry of the endothelial cells (EC) [62]. The gene discussed is DSG2; the disease is systemic sclerosis.